To describe an alternative model of psychiatric outpatient care for patients with mood and anxiety disorders (the Mood Disorders Association of British Columbia Psychiatric Urgent Care Program or the MDA Program) using group medical visits (GMV) and (or) email communications in lieu of individual follow-up appointments.
• The model of care was offered by a small group of psychiatrists and results may be different within other communities and (or) with other psychiatrists.
A ccess to psychiatric care in Canada remains problematic. Patients with nonemergent care needs and nonpsychotic disorders (that is, predominately mood and anxiety disorders) have difficulty accessing timely and comprehensive care from a psychiatrist. In British Columbia, 83% of patients who were diagnosed with a mental disorder received their only care from an FP. 1 Further, a survey conducted with FPs in British Columbia suggests that the wait time from an FP referral to psychiatric treatment exceeds 5 months. 2 Hence many FP no longer even attempt to access psychiatric care for their patients.
We have long felt that the above is unacceptable in terms of medical care and services. To address this, we have developed a program called the MDABC Psychiatric Urgent Care Program (henceforth referred to as the MDA Program), which appears to be more efficient and offers potential cost savings to health funders. Our program is based on 4 tenets: encourage and empower patients to become informed consumers; GMVs in lieu of individual follow-up visits; email communication to increase patient access and in lieu of individual follow-up visits; and house the program in a milieu that offers support, advocacy, and reduces stigma.
Program Overview
In March 2009, 2 psychiatrists initiated a collaborative project with the MDABC, a not-for-profit agency, to offer in-house psychiatric assessment and treatment for MDABC members. The program began with 2 doctors, each working one-half day per week. As of January 2013, the program had 4 doctors, each working slightly over 1 full day per week (1.1 full-time equivalents, total psychiatric staff). From the inception of the MDA Program in March 2009 through December 1, 2012, we have assessed 3976 patients. We assess about 30 patients per week (1500 per year), compared with an average of 214 patients assessed by a full-time (1.0 full time equivalents) outpatient psychiatrist using a traditional model of care (based on data from British Columbia MSP reports, 2011). About 60% of patients assessed have some follow-up contact with the MDA Program, either by attending a GMV or using email communications with the psychiatrist. Currently the wait time for new patients to be assessed is 32 days, compared with a wait time of 5 to 6 months for an outpatient psychiatric consultation in our community.
After preliminary registration (intake), patients are seen for a standard initial psychiatric assessment of 45 to 60 minutes. The psychiatrist then dictates a comprehensive consultation report that includes the preferred diagnosis and detailed treatment recommendations. This report is sent to both the referring FP and also directly to the patient so that all assessed patients are clearly informed about our recommended treatment plan. After the initial individual psychiatric assessment, the only direct face-to-face contact with psychiatrists we offer are GMVs. GMVs are a shared 60-minute medical follow-up visit in which multiple patients (in our case 6 to 12 patients) with similar conditions (mood and anxiety disorders) meet simultaneously with the psychiatrist. There is no user fee to attend GMVs, as it is a billable MSP item, it is optional and available to all patients at anytime. We typically have 2 psychiatrists per GMV, and each patient is allotted about 5 to 10 minutes of individual exchange with the psychiatrist. However, as the broad treatment options for mood and anxiety disorders Résultats : Le modèle de soins du programme ATH est significativement plus rentable que les soins psychiatriques externes individuels ou que le centre de santé mentale de l'autorité sanitaire pour les patients souffrant de maladie modérée à grave. Patients et médecins de famille étaient très satisfaits du modèle de soins et des CMG offerts. Le modèle de soins du programme ATH semble être efficace et rentable,  et les patients et médecins référents semblent satisfaits des soins offerts par Lastly, the MDA Program offers an option to email with the psychiatrist. Email communication can be used to ask basic questions about ongoing care, or as a means of ongoing treatment in lieu of individual or GMV follow-up. All patients sign an informed consent at intake if they wish to email with the psychiatrist. This email consent form has been vetted, revised, and approved for our MDA Program by the Canadian Medical Protections Association (October 2011). About 30% of patients assessed in the MDA Program communicate with the psychiatrist with at least 1 email.
Conclusion :
To evaluate the MDA Program, we conducted a cost comparison analysis of the MDABC model of care, compared with traditional outpatient psychiatric care (that is, mental health centres and private outpatient psychiatric office care). In addition, we collected data on patient and FP satisfaction with the MDA Program. In this paper, we describe these findings. 
Cost Comparison Analysis

Subjects and Materials
The CGI 3 was administered to all patients at intake in the MDA Program (2009 to 2011) and patients were stratified into 3 groups: mild illness (CGI 1 to 3; 15% of MDA Program patients), moderate illness (CGI 4; 30% of MDA Program patients), and severe illness (CGI 5 to 6; 55% of MDA Program patients). The total number of psychiatric and nursing visits for each severity category was based on estimates from senior physicians and administrators in each category. Figure 1 shows the annual cost per patient in the MDA Program (using GMVs for follow-up visits), average costs of a private psychiatrist offering assessment and individual follow-up care, and a low and high range in a health authority using psychiatrists, FPs, and nurses for intake and follow-up care. As noted, the cost in the MDA Program for patients with moderate to severe illness was between onethird and one-sixth of the cost of the other 2 models. See Table 1 for assumptions used to estimate costs (that is, the number of visits with medical professionals). Procedure and Materials. Participants completed a survey asking questions about their satisfaction level with the MDA Program assessment. They responded to 8 items asking about their experience with the assessment process ( Table  2 ). Participants were also asked to report the reasons they decided to attend the MDA Program assessment (multiple responses were allowed). Patients completed the survey after their initial assessment and returned the survey to the research assistant who was in the waiting area at the clinic.
Results
Patient and FP Satisfaction With the MDA Program
GMV Patient Satisfaction Survey
Subjects. All of the patients who attended 1-hour, dropin GMVs from November 24, 2010, to January 5, 2011 (n = 153) were invited to participate in the GMV Patient Satisfaction Survey. Among the 153 patients, 75 (28 males) were unique patients. A total of 51 completed the survey, for a return rate of 68%. There were 86.3% of participants diagnosed with a mood disorder (that is, MDD, depression, BD I, or BD II), 9.8% were diagnosed with an anxiety disorder, and the remaining 3.9% reported their diagnosis as other. About 45.1% of patients had concurrent mood and anxiety disorders, and 9.8% had concurrent mood or anxiety disorders with substance abuse. Most participants (58.8%) had attended 6 or more GMVs; 17.6% had attended 4 to 6 sessions, 9.8% had attended 1 to 3 sessions, and for the remaining 13.7%, this was their first session.
Procedure and Materials. The GMV Patient Satisfaction
Survey asked patients about the reasons for their participation, previous psychiatric care, and their level of satisfaction with the GMV (Table 3) .
FP Satisfaction Survey
Subjects. A total of 72 referring FPs were identified from the MDA Program database as potential participants for the FP user Satisfaction Survey. A total of 19 (10 males) FPs participated in the survey.
Procedure and Materials. The research assistant faxed a survey to all 72 FPs once, followed by a phone call to solicit participation. FPs were invited to complete the survey and return it at their convenience. The return rate was 26.4%. The survey was designed to gain information about FP satisfaction with the MDA Program (Table 4 ).
Results
Overview
All analyses performed were descriptive. As we were trying to gauge patient and FP satisfaction with the program, participants completed a survey asking questions about their satisfaction level with the MDA Program. For the new patient and GMV patient satisfaction surveys, participants responded to items by indicating if they felt the service received was excellent, very good, good, fair, or poor. For the FP Satisfaction Survey, participants were asked to indicate their agreement level (strongly agree, agree, disagree, or strongly disagree) with statements about the program. For all surveys, we report the number of participants and per cent of the sample who indicated each specific response to each item.
New Patient Satisfaction
For 6 out of the 8 items in the survey (Table 2 ), most participants indicated that their experience was either excellent or very good. For the remaining 2 items, most reported their experience was excellent, very good, or good. See Table 2 for a detailed report of each item.
In terms of reasons that new patients attended the MDA Program, 19 patients (29.7%) reported that their FP had referred them. Eighteen patients (28.1%) said they came for assessment because of the shorter wait time to see a psychiatrist. Ten patients (15.6%) reported that they wanted information from a psychiatrist. Other reasons included seeking support from other patients (10.9%) and financial constraints (10.9%).
Overall, the new patients surveyed indicated a very high level of satisfaction with the wait time for initial consultation and the overall quality of care and information they received in their first appointment.
GMV Patient Satisfaction
In the GMV Patient Satisfaction Survey ( Table 3 ) in 4 of 6 items most participants indicated that their experience was excellent. For the remaining 2 items, most reported their experience was either excellent or very good.
In terms of why participants attended a GMV (multiple responses allowed), 34 patients (67%) reported that they attended the GMVs because of a shorter waiting time to access psychiatric care. Thirty-four patients (67%) said they attended GMVs because of the helpful information about medication side effects and symptom monitoring from the psychiatrists. Twenty-eight patients (55%) reported that they attended the GMVs because of the support and reassurance from others. Other reasons included the clinic being closer to home than other programs or psychiatrists (18%), preference to attend a group visit to one-on-one individual visits (14%), and more frequent and regular access to psychiatrists (12%).
Overall, the patients indicated a very high level of satisfaction with the wait time for initial consultation and the quality of medical information and consultations provided in GMVs.
FP Satisfaction
Participating FPs completed a survey indicating their agreement level with 7 statements asking about their experience with the program ( Table 4 ). All statements were written from a positive standpoint, such that agreeing with the statement suggests a positive experience with the program, while indicating disagreement with an item suggests a negative experience. For 6 out of 7 items, most FPs were in strong agreement with the statements. For the remaining item, 42.1% agreed. See Table 4 for a detailed report of each item.
Discussion
In our paper, we have described an alternative model for outpatient psychiatric follow-up care for patients with mood and anxiety disorders. With this program, we appear to have shortened wait lists for referral by one-fifth, and we are assessing more than 6 times the amount of new assessments, compared with traditional psychiatric outpatient care. In addition, our costs per patient appear to be one-third to onesixth that of traditional outpatient care in our community. Not only is our program efficient and cost-effective, but also our data also show that our patients are satisfied with both the assessment process and the follow-up care (GMVs), and referring FPs report a very high level of satisfaction as well.
The most significant limitations of our evaluation are related to the use of satisfaction questionnaires for the collection of much of the data. Satisfaction questionnaires, especially without an incentive (for example, a monetary reward for participation), generally produce low response rates. In one study 4 conducted with cancer patients, the average response rate was 64%, which they report as a relatively high response rate. The average response rate for our patient questionnaires was 60%, which is similar to that reported in the above-cited paper. 4 FP response rates are even lower than studies with the general population, likely because FPs have demanding schedules and participating in a survey is not a high priority. 5 In addition, owing to FP expertise, they are frequently asked to participate in surveys, possibly making them more reluctant to participate. 5
In addition, much of our data on patient and FP satisfaction come from questionnaires without the use of a comparison group. In other words, these data are simply descriptive. Therefore, we cannot be sure that patient and FP ratings of a traditional psychiatric practice would be better, worse, or equal to the ratings received at our program. We have addressed this limitation, in the context of patient satisfaction with GMVs, in a subsequent study, 6 and found that patients rated their experience with GMVs to be equal to their experience with traditional one-on-one psychiatric care. In addition, previous research done on GMVs, discussed in detail below, has found that patients attending GMVs report equal levels or higher levels of satisfaction when compared with control groups.
GMVs are not new or novel. GMVs have been used in medicine for more than a decade. The GMV model is increasingly used in other aspects of medicine, specifically in the treatment of chronic illnesses, such as hypertension, diabetes, or asthma. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] Given that mental illness is also a chronic condition, it seems logical to adopt this model in psychiatry, as it affords the opportunity to assess patients with homogeneous chronic illnesses in a more efficient format. Further, research on group, compared with individual, therapy (for example, psychotherapy, cognitive-behavioural therapy, or mindfulness therapy) shows that group therapy is equal in efficacy to individual treatment. [18] [19] [20] [21] [22] The GMV model was originally developed by Dr Edward Noffsinger at Kaiser Permanante. Noffsinger's aim in developing this model of treatment was to improve efficiency, accessibility, and quality of care. 23 Jaber et al 11 conducted a comprehensive review of the GMV literature and concluded that this model of treatment is in fact a promising approach for managing chronic illness. Specifically, Jaber et al 11 found that across all studies reviewed, compared with control groups, patients attending GMV reported higher levels of satisfaction with care, demonstrated a decreased use of certain health services (that is, emergency department visits, visits to specialists, and hospitalizations), and received better care (for example, receiving more preventative procedures and having medications reviewed). Reasons that patients preferred GMVs included the benefits provided by group interaction (such as support and advice from other group members), more time spent with the physician, more education, and increased access to prescription refills and examinations. In addition, physician satisfaction was high across all GMV studies, likely because physician productivity increased in the GMV modality.
More recent studies continue to show the GMV method of treatment is either equivalent to or superior to the traditional method of patient care. Patients attending GMVs with diabetes and heart disease demonstrate improved disease-specific health outcomes when compared with control subjects. 8, 12, 16, 17 In a year-long observational study of patients with diabetes and risk factors for heart disease, Geller et al 10 found that patients with high attendance to GMVs (compared with those with low attendance) had decreased depression and loneliness and improved quality of life (as measured by general health, vitality, bodily pain, and mental health). In a different patient population, Meehan et al's 13 findings showed an extremely high level of patient satisfaction and the preference to attend future GMVs in cancer patients receiving bone marrow transplants. Dorsey et al 9 also examined the effectiveness of GMVs in a different patient population, those with Parkinson disease. While they did not find GMVs to be superior to traditional treatment in this population, they did find the 2 modalities to be equal in efficacy. The results appear quite consistent throughout the literature; GMVs are an effective means of managing care in patients with chronic illness.
Email communication or some type of electronic communication is an essential aspect of all other aspects of our business and social communications. Somehow, email has not caught on in medicine. Seeman and Seeman 24 originally cautioned about this type of patient communication, but in a complete about-face, 25 urged physicians to embrace email as a more efficient means of patient communication. Electronic communication (email, instant messaging, and social networks) with the treating psychiatrist allows patients further access to their physician and adds another dimension to follow-up care. [25] [26] [27] Previous research has shown that electronic communication is associated with increased patient satisfaction 28, 29 and better health outcomes. 28, 30, 31 Email in particular offers patients quicker access for basic medical services and offers a more useful response system for many routine clinical situations that currently require telephone communication or a scheduled individual office visit. Further, in an age of medical consumerism, patients know a great deal about their medical disorders and we need to welcome informed consumers and collaborators in their medical care. This type of expectation can be very empowering for patients, particularly those with mood and anxiety disorders.
Conclusions
This model of care (MDA Program) is not for everyone. Indeed, it is unlikely to work for people who cannot assume a degree of responsibility for their care or who lack insight (for example, those with chronic schizophrenia or dementia). However, for most patients who are seen in outpatient departments, mental health clinics, or private psychiatric offices, we believe this model, or some aspect of it, will result in more efficient and cost-effective care.
Many psychiatrists will feel uncomfortable with this model, as it is clearly not how we have been trained. While it will be outside the comfort zone of many psychiatrists, we would suggest that it will result in seeing far more patients and offering a better service to our FP colleagues who are often frustrated with our long wait lists or closed practices. Likewise, patients who have had traditional individual care are often uneasy or skeptical about GMVs or email communications, initially. Our experience would suggest that most patients, once they experience this type of care, are quite satisfied, and a significant minority actually prefer it over individual care.
